(Q50538839)

15 March 2018

title

Clinical trial experience with extended-release niacin (Niaspan): dose-escalation study. (English)

1 reference

15 March 2018

1 reference

A C Goldberg

1

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

15 March 2018

American Journal of Cardiology

published in

1 reference

15 March 2018

volume

82

1 reference

15 March 2018

issue

12A

1 reference

15 March 2018

page(s)

35U-38U; discussion 39U-41U

1 reference

15 March 2018

Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levels

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

The effect of nicotinic acid and acipimox on lipoprotein(a) concentration and turnover

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

The prevalence of side effects with regular and sustained-release nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

Efficacy and safety of controlled-release niacin in dyslipoproteinemic veterans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

Niacin and hepatic failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

Fulminant hepatic failure after ingestion of sustained-release nicotinic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

Acute hepatic failure associated with the use of low-dose sustained-release niacin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900952-7

10.1016/S0002-9149(98)00952-7

7 January 2021

Identifiers

DOI

1 reference

15 March 2018

release_4moeangeyfe4floh3emptuc45e

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4moeangeyfe4floh3emptuc45e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

15 March 2018